P132 Overexpression of miR-376a-3p in exosomes circulating in peripheral blood of patients with Crohn's disease

E Caparrós,I García,L Madero Velázquez,C Mira,A Martínez,A Gutiérrez Casbas,R Francés

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0262

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background MicroRNAs (miRs) can modulate the development and/or progression of chronic inflammation in patients with Crohn's disease (CD), influencing the efficacy of treatments. Aim The objective was to assess the miRs content of circulating exosomes in the peripheral blood of patients with CD to identify new biomarkers useful in disease management. Methods Patients with CD diagnosed and followed up at the Hospital General Universitario de Alicante and healthy controls were included. Extracellular vesicles were isolated from serum and exosomes were quantified by "Nanoparticle Tracking Analysis" (NTA), confirmed by Transmission Electron Microscopy (TEM) and by specific markers (Tsg101, CD63, CD81) by Western blot, performing an expression analysis of a non-targeted panel of human miRs from exosomal RNA. Patient and control samples were also subjected to enzyme-linked immunosorbent assay (ELISA) measurement of different target-predicted protein substrates. Results Thirty patients and ten controls were included in the study. Patients were 42±9 years old, disease duration 62±9 months, 40% women and 80% showed ileal or ileocolonic involvement. Six patients (20%) had perianal disease. Ninety-three per cent were undergoing biological treatment with infliximab (IFX, n=13), adalimumab (ADA, n=8) or ustekinumab (USTE, n=7). A significant increase in exosome concentration was observed in the serum of patients vs controls. NTA and TEM confirmed the size and purity of the obtained exosomes. The distribution in the expression of miRs and its differential analysis showed a significant increase in miR-376a-3p as well as a reduction in miR-20a-5p in patients vs. healthy controls. Functional analysis of miR-376a-3p determined its interaction with gene targets involved in autophagy (ATG4C), TGF-b signaling (ACVR1C) and cell survival (PIK3R1, IGF1R). Protein levels of these substrates indicated the potential control of TGF-beta signaling pathway by the downregulation of ACVR1C, and the increase in survival pathway measured by IGFR1 presence in patient’s serum. Conclusion CD patients show a higher number of circulating exosomes, with an overexpression of miR-376a-3p. The involvement of this microRNA in different intracellular signaling pathways suggests its participation in the unbalance of the immune activity present in CD.

gastroenterology & hepatology

What problem does this paper attempt to address?

This paper aims to solve the problem of over - expression of microRNAs (miRs) in exosomes in the peripheral blood circulation of patients with Crohn's disease (CD), especially the over - expression of miR - 376a - 3p. The research background indicates that miRs can regulate the development and progression of chronic inflammation and affect the treatment effect of CD patients. Therefore, the main goal of the study is to evaluate the content of miRs in exosomes in the peripheral blood circulation of CD patients in order to identify new biomarkers that can be used for disease management. Specifically, the study addresses the problem through the following methods: 1. **Sample selection**: The study included CD patients diagnosed and followed up at the General Hospital of the University of Alicante and a healthy control group. 2. **Exosome isolation and identification**: Extracellular vesicles were isolated from serum, and the size and purity of exosomes were confirmed by nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and Western blot detection of specific markers (such as Tsg101, CD63, CD81). 3. **miRs expression analysis**: Non - targeted human miRs expression profiling was performed on RNA extracted from exosomes. 4. **Protein level measurement**: The levels of different predicted target protein substrates were measured using enzyme - linked immunosorbent assay (ELISA). The research results show that, compared with the healthy control group, the number of exosomes in the serum of CD patients increased significantly, and the expression of miR - 376a - 3p was significantly up - regulated, while the expression of miR - 20a - 5p decreased. Functional analysis shows that miR - 376a - 3p interacts with gene targets related to autophagy (ATG4C), TGF - β signaling pathway (ACVR1C), and cell survival (PIK3R1, IGF1R). These findings suggest that miR - 376a - 3p may be involved in the process of immune activity imbalance in CD, especially in the regulation of the TGF - β signaling pathway and the enhancement of cell survival pathways. In conclusion, this study reveals the increase in the number of circulating exosomes and the over - expression of miR - 376a - 3p in CD patients, which may help to understand the pathogenesis of CD and provide new biomarkers for the diagnosis and treatment of the disease.

P132 Overexpression of miR-376a-3p in exosomes circulating in peripheral blood of patients with Crohn's disease

Peripheral blood mononuclear cell microRNAs are novel biomarkers for diagnosing and monitoring Crohn's disease

P121 Characterisation of the miRNAome in Crohn’s Disease patients reveals transcriptomic changes associated with tissue composition and drug treatment

P002 Regulation of miR-338-3p and miR-378a-3p in the intestinal mucosa of Crohn’s disease: Potential targets for modulating inflammation

MicroRNAs overexpressed in Crohn's disease and their interactions with mechanisms of epigenetic regulation explain novel aspects of Crohn's disease pathogenesis

Mucosal Micrornas Expression Profiles Before And After Exclusive Enteral Nutrition Therapy In Adult Patients With Crohn'S Disease

Altered Microrna Expression in Inflamed and Non-Inflamed Terminal Ileal Mucosa of Adult Patients with Active Crohn'S Disease

Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients

Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease

microRNA–mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease

Exosomal miR-29b of Gut Origin in Patients With Ulcerative Colitis Suppresses Heart Brain-Derived Neurotrophic Factor

P021 Higher TNFα and IL-6 mucosal levels in ulcerative colitis patients with more severe endoscopic activity

Unraveling the blood microbiome: novel insights into inflammasome responses in Crohn’s disease

P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease

Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn's Disease

Characterization of the MicroRNA profile in rheumatoid arthritis plasma exosomes and their roles in B-cell responses

PLGA microspheres carrying miR-20a-5p improved intestinal epithelial barrier function in patients with Crohn's disease through STAT3-mediated inhibition of Th17 differentiation

Exosome-Encapsulated Micrornas As Circulating Biomarkers For Colorectal Cancer

P632 Isolation of a novel metalloproteinases transcriptional signature with robust anti-TNF therapy predictive power in patients with Ulcerative Colitis

P099 Serum proteomic analysis reveals novel biomarkers associated with disease activity in pediatric patients with Crohn’s disease

Exosomal miR-103a-3p from Crohn's Creeping Fat-Derived Adipose-Derived Stem Cells Contributes to Intestinal Fibrosis by Targeting TGFBR3 and Activating Fibroblasts